Therapeutic Efficacy and Mechanism of Celecoxib for Hepatocellular Carcinoma
博士 === 國立中山大學 === 生物醫學研究所 === 102 === Hepatocellular carcinoma (HCC) is the one of most common malignancies in Taiwan. Current HCC therapies include surgery, chemotherapy, radiofrequency ablation and target therapy. However, the overall prognosis for HCC remains poor. The aim of study is to evaluate...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2014
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/kc95aw |